Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial.
Year of publication
2012
Authors
Joensuu, Heikki; Kellokumpu-Lehtinen, Pirkko-Liisa; Huovinen, Riikka; Jukkola-Vuorinen, Arja; Tanner, Minna; Kokko, Riitta; Ahlgren, Johan; Auvinen, Päivi; Paija, Outi; Helle, Leena; Villman, Kenneth; Nyandoto, Paul; Nilsson, Greger; Pajunen, Marjo; Asola, Raija; Poikonen, Paula; Leinonen, Mika; Kataja, Vesa; Bono, Petri; Lindman, Henrik
Show moreOrganizations and authors
Tampere University
Tuntematon
University of Eastern Finland
Kataja Vesa
Tampere University Hospital
Tanner Minna
Nyandoto Paul
Kellokumpu-Lehtinen Pirkko-Liisa
Kokko Riitta
Kataja Vesa
Publication type
Publication format
Article
Parent publication type
Journal
Article type
Original article
Audience
ScientificPeer-reviewed
Peer-ReviewedMINEDU's publication type classification code
A1 Journal article (refereed), original researchPublication channel information
Journal/Series
Parent publication name
Volume
30
Issue
1
Pages
11-18
ISSN
Publication forum
Open access
Open access in the publisher’s service
Yes
Open access of publication channel
Fully open publication channel
Self-archived
Unknown
Other information
Fields of science
Others; Cancers
Internationality of the publisher
International
International co-publication
Yes
Co-publication with a company
Unknown
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes